🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 98 of 200 · A–Z by INN

  1. insulin aspart + insulin aspart protamine

    NOVOMIX 30 FLEXPEN NovoThirteen

    TGA: approved

  2. insulin aspart protamine recombinant

    NOVOLOG MIX 50/50

    SUBCUTANEOUS FDA: approved

  3. insulin aspart recombinant

    NOVOLOG PENFILL

    SUBCUTANEOUS FDA: approved

  4. insulin aspart-szjj

    MERILOG

    SOLUTION FDA: approved

  5. insulin aspart-xjhz

    KIRSTY

    SOLUTION FDA: approved

  6. insulin degludec

    RYZODEG

    SUBCUTANEOUS FDA: approved · EMA: approved · PMDA: approved

    A10AE06

  7. insulin degludec + insulin aspart

    RYZODEG PENFILL NovoThirteen

    TGA: approved

  8. insulin degludec / insulin aspart

    RYZODEG

    PMDA: approved

  9. insulin detemir

    LEVEMIR FLEXPEN NovoThirteen

    INJECTION FDA: approved · EMA: approved · TGA: approved

    A10AE05

  10. insulin detemir recombinant

    LEVEMIR FLEXTOUCH

    SUBCUTANEOUS FDA: approved

  11. insulin glargine

    OPTISULIN Sanofi-aventis Healthcare Pty Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved

    A10AE04

  12. insulin glargine [insulin glargine biosimilar 1]

    INSULIN GLARGINE BS [LILLY]

    PMDA: approved

  13. insulin glargine recombinant

    TOUJEO SOLOSTAR

    INJECTION FDA: approved

  14. insulin glargine-aglr

    REZVOGLAR

    INJECTION FDA: approved

  15. insulin glargine-aldy

    LANGLARA Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    SUBCUTANEOUS FDA: approved

  16. insulin glargine-yfgn

    SEMGLEE

    INJECTION FDA: approved

  17. insulin glulisine

    APIDRA Sanofi-aventis Healthcare Pty Ltd

    EMA: approved · TGA: approved

    A10AB06

  18. insulin glulisine recombinant

    APIDRA SOLOSTAR

    SUBCUTANEOUS FDA: approved

  19. insulin human

    COMBIMARV

    SUBCUTANEOUS FDA: approved · EMA: approved

    A10AB01;A10AC01

  20. insulin human (rdna)

    ACTRAPHANE

    EMA: approved

    A10AD01

  21. insulin icodec

    AWIQLI

    SOLUTION FDA: approved · EMA: approved · PMDA: approved

    A10AE57

  22. insulin isophane human

    HUMULIN NPH NovoThirteen

    TGA: approved

  23. insulin lispro

    HUMALOG

    SUBCUTANEOUS FDA: approved · EMA: approved · TGA: approved

    A10AB04

  24. insulin lispro + insulin lispro protamine

    HUMALOG MIX25 KWIKPEN

    TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources